CD274 and hyperinsulinemic hypoglycemia, familial, 4: Similarly, PD-L1 expression and microsatellite instability (MSI) or mismatch repair deficiency (dMMR), which have established roles in metastatic immunotherapy are being investigated for integration into neoadjuvant or adjuvant immunotherapy trials.